Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 208

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Allergen immunotherapy for the prevention of allergy: A systematic review and meta‐analysis

Open access
Kristiansen, Maria, Dhami, Sangeeta, Netuveli, Gopal, Halken, Susanne, Muraro, Antonella, Roberts, Graham, Larenas‐Linnemann, Desiree, Calderón, Moises A., Penagos, Martin, Du Toit, George, Ansotegui, Ignacio J., Kleine‐Tebbe, Jörg, Lau, Susanne, Matricardi, Paolo Maria, Pajno, Giovanni, Papadopoulos, Nikolaos G., Pfaar, Oliver, Ryan, Dermot, Santos, Alexandra F., Timmermanns, Frans, Wahn, Ulrich, Sheikh, Aziz · 2017 · Pediatric Allergy and Immunology

Abstract

Background: There is a need to establish the effectiveness, cost‐effectiveness, and safety of allergen immunotherapy (AIT) for the prevention of allergic disease. Methods: Two reviewers independently screened nine international biomedical databases. Studies were quantitatively synthesized using random‐effects meta‐analyses. Results: A total of 32 studies satisfied the inclusion criteria. Overall, meta‐analysis found no conclusive evidence that AIT reduced the risk of developing a first allergic disease over the short term (RR = 0.30; 95% CI: 0.04–2.09) and no randomized controlled evidence was found in relation to its longer‐term effects for this outcome. There was, however, a reduction in the short‐term risk of those with allergic rhinitis developing asthma (RR = 0.40; 95% CI: 0.30–0.54), with this finding being robust to a pre‐specified sensitivity analysis. We found inconclusive evidence that this benefit was maintained over the longer term: RR = 0.62; 95% CI: 0.31–1.23. There was evidence that the risk of new sensitization was reduced over the short term, but this was not confirmed in the sensitivity analysis: RR = 0.72; 95% CI: 0.24–2.18. There was no clear evidence of any longer‐term reduction in the risk of sensitization: RR = 0.47; 95% CI: 0.08–2.77. AIT appeared to have an acceptable side effect profile. Conclusions: AIT did not result in a statistically significant reduction in the risk of developing a first allergic disease. There was, however, evidence of a reduced short‐term risk of developing asthma in those with allergic rhinitis, but it is unclear whether this benefit was maintained over the longer term. We are unable to comment on the cost‐effectiveness of AIT.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/pai.12661

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 208

Metadata

Authors
Kristiansen, M., Dhami, S., Netuveli, G., Halken, S., Muraro, A., Roberts, G., Larenas‐Linnemann, D., Calderón, M. A., Penagos, M., Du Toit, G., Ansotegui, I. J., Kleine‐Tebbe, J., Lau, S., Matricardi, P. M., Pajno, G., Papadopoulos, N. G., Pfaar, O., Ryan, D., Santos, A. F., Timmermanns, F., Wahn, U., & Sheikh, A.
Venue
Pediatric Allergy and Immunology
Publisher
Wiley
Published
2016-12-12
Volume
28
Issue
1
Pages
18-29
ISSN
  • 0905-6157 (ISSN-L)
  • 1399-3038
OpenAlex
W2521983393
Cited by
208
References
2
FWCI
3.65
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Allergen immunotherapy for the prevention of allergy: A systematic review and meta‐analysis. https://app.cochat.ai/papers/10.1111/pai.12661
The paper
Kristiansen, M., Dhami, S., Netuveli, G., Halken, S., Muraro, A., Roberts, G., Larenas‐Linnemann, D., Calderón, M. A., Penagos, M., Du Toit, G., Ansotegui, I. J., Kleine‐Tebbe, J., Lau, S., Matricardi, P. M., Pajno, G., Papadopoulos, N. G., Pfaar, O., Ryan, D., Santos, A. F., . . . Sheikh, A. (2017). Allergen immunotherapy for the prevention of allergy: A systematic review and meta‐analysis. Pediatric Allergy and Immunology. https://doi.org/10.1111/pai.12661

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.